| HIV‐1 entry inhibitors: A review of experimental and computational studies T Mostashari Rad, L Saghaie, A Fassihi Chemistry & Biodiversity 15 (10), e1800159, 2018 | 27 | 2018 |
| Study of CXCR4 chemokine receptor inhibitors using QSPR and molecular docking methodologies T Mostashari-Rad, R Arian, H Sadri, A Mehridehnavi, M Mokhtari, ... Journal of Theoretical and Computational Chemistry 18 (04), 1950018, 2019 | 26 | 2019 |
| Molecular dynamics simulation, 3D-pharmacophore and scaffold hopping analysis in the design of multi-target drugs to inhibit potential targets of COVID-19 N Fayyazi, T Mostashari-Rad, JB Ghasemi, MM Ardakani, F Kobarfard Journal of Biomolecular Structure and Dynamics 40 (22), 11787-11808, 2022 | 7 | 2022 |
| Gp41 inhibitory activity prediction of theaflavin derivatives using ligand/structure-based virtual screening approaches T Mostashari-Rad, L Saghaei, A Fassihi Computational Biology and Chemistry 79, 119-126, 2019 | 7 | 2019 |
| Discovery of novel RARα agonists using pharmacophore-based virtual screening, molecular docking, and molecular dynamics simulation studies A Atefeh Ghorayshian, Mahshid Danesh, Tahereh Mostashari-Rad* PLOS ONE 18 (8), 2023 | 3 | 2023 |
| Synthesis, molecular docking and molecular dynamics simulation of 2-thioxothiazolidin-4-one derivatives against Gp41 N Tamiz, T Mostashari-Rad, A Najafipour, S Claes, D Schols, A Fassihi Current HIV Research 19 (1), 47-60, 2021 | 3 | 2021 |
| Novel 2-alkylthio-1-benzylimidazole-5-carboxylic Acid Derivatives Targeting Gp41: Design, Synthesis, and In Vitro Anti-HIV Activity Evaluation T Mostashari-Rad, S Claes, D Schols, P Shirvani, A Fassihi Current HIV Research 20 (5), 380-396, 2022 | 1 | 2022 |
| Machine Learning-Assisted Prediction of Biological Activities of Chemical Compounds on NMDA Receptors T Mostashari-Rad, M Momenzadeh Journal of Visualized Medicine 1 (4), 2024 | | 2024 |
| Molecular dynamics simulation, 3D-pharmacophore and scaffold hopping analysis in the design of multi-target drugs to inhibit potential targets of COVID-19 M Ardakani, F Kobarfard | | |
Afshin FassihiProfessor of Medicinal Chemistry, Isfahan University在 pharm.mui.ac.ir 的电子邮件经过验证
Afshin FassihiProfessor of Medicinal Chemistry, Isfahan University在 pharm.mui.ac.ir 的电子邮件经过验证
Fahimeh GhasemiIsfahan University of Medical Sciences在 amt.mui.ac.ir 的电子邮件经过验证
Farhad ShiriniUniversity of Guilan在 guilan.ac.ir 的电子邮件经过验证